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ABSTRACT
Introduction: Corneal endothelial damage following
phacoemulsification is still one of the major concerns
of modern day cataract surgery. Although many
techniques have been proposed, the risks of posterior
capsular rupture and corneal endothelium damage
persist. In theory, damage to the corneal endothelium
is minimised by delivering the lowest phaco energy
only in the direction necessary to emulsify the lens
nucleus. Hence, it is believed that the bevel of the
needle should be turned towards the nucleus or the
nuclear fragment (ie, bevel-down. However, there is a
difference of opinion among ophthalmologists with
reference to the phaco tip’s position (bevel-up vs
bevel-down) during phacoemulsification. This subject
has not been extensively studied earlier.
Methods and analysis: This is a prospective, triple-
blinded (trial participant, outcome assessor and the
data analyst), randomised controlled trial with 2 parallel
groups and with an allocation ratio of 1:1. It will be
conducted in a tertiary care hospital, Mangaluru, India.
The objective is to compare the postoperative central
corneal thickness changes between the bevel-up and
bevel-down techniques of phacoemulsification. Patients
aged >18 years with immature cataract undergoing
phacoemulsification will be selected for the study. The
important exclusion criteria are the history of previous
significant ocular trauma or intraocular surgery,
corneal pathology, pseudoexfoliation syndrome,
intraocular inflammation, a preoperative fully dilated
pupil <6 mm, anterior chamber depth <2.5 mm and
nuclear sclerosis grade >4. After randomisation,
patients will undergo phacoemulsification surgery
either by a bevel-up or bevel-down procedure. With an
estimated power of 80%, the calculated sample size is
55 patients in each group. The recruitment will start
from April 2016.
Ethics and dissemination: Yenepoya University
Ethics Committee, India has approved the study
protocol (YUEC/148/2016 on 18 February 2016).
It complies with the Declaration of Helsinki, local laws
and the International Council for Harmonization-good
clinical practices.
Trial registration number: CTRI/2016/02/006691;
Pre-results.
INTRODUCTION
Corneal endothelial damage following pha-
coemulsiﬁcation is still one of the major con-
cerns of modern day cataract surgery.
Introduction of different techniques and
certain innovations in the phaco instrumen-
tation have reduced the incidence of post-
operative corneal endothelial loss. At every
stage of cataract surgery, the surgeon has
options to optimise corneal endothelial
safety. This includes relevant parameters in
various phaco platforms, surgical techniques,
materials used and patient characteristics
such as the grade of the cataract, age of the
patient and the presence of corneal disease.
Several mechanisms have been proposed
for endothelial cell damage during phacoe-
mulsiﬁcation; these include mechanical
contact with nuclear fragments, irrigation
ﬂow, turbulence and movement of ﬂuid,
direct trauma caused by instruments or lens
fragments, and formation of cavitation
bubbles.1 2
Strengths and limitations of this study
▪ This study attempts to find the most cornea-
friendly technique of clear corneal phacoemulsifi-
cation with regard to phaco tip’s position.
▪ Study findings would be more pertinent to those
who are at high risk of corneal decompensation
(ie, small pupil, short anterior chamber depth,
high nuclear grade, large nucleus, older age, etc)
following phacoemulsification.
▪ Multiple factors can affect the study outcome
(central corneal thickness).
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In phacoemulsiﬁcation procedures the most important
predictor of corneal clarity in the early postoperative
period is inversely proportional to the amount of ultra-
sound energy used. For this reason, all of the major plat-
forms now use power modulation to reduce the amount
of phaco power necessary, either by varying the duty
cycle and pulse energy or by varying the pulse intervals
with microburst techniques.
Several phacoemulsiﬁcation techniques have been
developed and modiﬁed.3–7 Although many techniques
have been proposed, the risks of posterior capsular
rupture and corneal endothelium damage persist. In
theory, damage to the corneal endothelium is mini-
mised by delivering the lowest phaco energy only in the
direction necessary to emulsify the lens nucleus.
Furthermore, phacoemulsiﬁcation should occur in the
posterior chamber rather than in the iris plane or the
anterior chamber.8 Hence, it has traditionally been
believed that the bevel of the needle should be turned
towards the nucleus or the nuclear fragment (ie, bevel-
down).9 However, Faramarzi et al10 hypothesise that in
the bevel-up technique, the phaco tip, and therefore the
source of heat, are farther from the endothelial cells
than in the bevel-down technique and this decreases the
chance of endothelial cell damage. Further another clin-
ical trial by Raskin et al11 concluded in their study that
bevel-up tip position has a negative effect on corneal
endothelial cells compared with the bevel-down position.
Hence, there is a difference of opinion among ophthal-
mologists with respect to the phaco tip position during
phacoemulsiﬁcation. This subject has not been exten-
sively studied earlier, hence this study is planned.
OBJECTIVE
To compare the postoperative central corneal thickness
(CCT) changes between bevel-up and bevel-down tech-
niques of phacoemulsiﬁcation.
Trail design: Prospective randomised, parallel group,
exploratory, triple-blind (trial participant, outcome assessor
and the data analyst) trial with an allocation ratio of 1:1.
Trial registration: This trial is registered prospectively in
the Clinical trial registry of India (CTRI/2016/02/
006691) and the full trial protocol can be accessed
on http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=
14144&EncHid=&userName=CTRI/2016/02/006691.
METHODS
Ethics and dissemination: Written informed consent will be
taken from all study participants. It complies with the
Declaration of Helsinki, local laws and the International
Council for Harmonisation-good clinical practices
(ICH-GCP). After obtaining the written informed
consent (by SK), protected personally identiﬁable infor-
mation (PPII) will be replaced by the research identiﬁca-
tion code. Face sheets containing PPIIs will be removed
from the completed questionnaire. Access to master
code list will be limited to SK and DKS. Research data
will be stored securely in locked cabinets and the
relevant electronic data will be stored in the password-
protected computers and ﬁles. The intervention in this
trial is the standard treatment for the eligible partici-
pants and does not pose an additional risk. Hence, the
trial participants will not be eligible for any damage
compensation. Following analysis of the data, the results
will be presented in scientiﬁc forums and published in
scientiﬁc journals.
Study setting: Department of Ophthalmology, Yenepoya
Medical College Hospital, Yenepoya University, Mangaluru,
India.
Study period: January 2016 to December 2017.
Participants and methods
Inclusion criteria: Consecutive patients aged >18 years
with immature cataract undergoing phacoemulsiﬁcation
at Yenepoya Medical College Hospital, Mangaluru, India
will be selected for the study.
Exclusion criteria: History of previous signiﬁcant ocular
trauma or intraocular surgery, corneal pathology, pseu-
doexfoliation syndrome, intraocular inﬂammation, a pre-
operative fully dilated pupil smaller than 6 mm, anterior
chamber depth (ACD) <2.5 mm and nuclear sclerosis
grade >4. Cases with intraoperative complications, those
where direct chop could not be done and patients not
willing to participate in the study will be excluded.
Interventions (bevel-up and bevel-down
phacoemulsification groups)
Patients will be randomised into two groups, that is,
bevel-up and bevel-down. The phaco tip will be held in
the bevel-down position for the bevel-down group and in
bevel-up position for the bevel-up group whenever the
phaco tip is introduced into the anterior chamber. The
preoperative evaluation, rest of the surgical procedure,
phaco parameters and intraoperative and postoperative
evaluations will remain the same in both the groups. All
the surgeries will be performed by a single surgeon (SK).
Preoperative evaluation: In all the cases, a complete pre-
operative ocular examination will be performed includ-
ing uncorrected distance visual acuity (UDVA),
corrected distance visual acuity (CDVA), slit lamp evalu-
ation, applanation tonometry, posterior pole evaluation
with a non-contact 78 dioptre lens and indirect ophthal-
moscopy. The axial length (AL) and ACD will be mea-
sured by using an ultrasonic A-scan (Echorule Pro,
Biomedix Optotechnik & Devices). CCT will be mea-
sured using an ultrasound pachymeter (Pacscan 300P,
Ver 3 Rev U, Sonomed). The mean of 5 CCT readings
with an SD ≤0.09, with the patient ﬁxating at a target,
will be recorded. Nuclear hardness will be evaluated
clinically with slit lamp biomicroscopy according to the
colour of the nucleus based on the Lens Opacities
Classiﬁcation System III.12
Surgical procedure
Two limbal stab incisions will be made. The anterior
capsule will be stained with trypan blue dye after which,
2 Kaup S, et al. BMJ Open 2016;6:e012024. doi:10.1136/bmjopen-2016-012024
Open Access
the anterior chamber will be ﬁlled with hydroxypropyl
methylcellulose 2%. A capsulorhexis 5.0–5.5 mm in
diameter will be created with a needle cystotome. A
2.8 mm clear corneal incision will be made, followed by
hydrodissection and hydrodelineation of the nucleus.
Phacoemulsiﬁcation of the nucleus will be performed
using the phaco chop technique with a 30° 19-gauge
phaco tip. In both groups, the nucleus will be stabilised
with the phacoemulsiﬁcation tip, which is impaled with
moderate vacuum and low ultrasonic power. The
chopper will be advanced under the anterior capsule
until it can pass around the equator of the nucleus at the
nucleus–epinucleus border, 180° from the phaco tip. The
chopper will be advanced towards the phaco tip splitting
the nucleus into half. By rotating the lens, several pieces
of nucleus are broken (chopped). The pieces will then
be emulsiﬁed. Following this, irrigation/aspiration of cor-
tical material will be performed with a bimanual irriga-
tion/aspiration cannula. Next, a foldable hydrophilic
acrylic intraocular lens with ultraviolet absorbing optic
and square edge design (Acryfold, Appasamy ocular
devices, Pondicherry, India) will be implanted in the cap-
sular bag using a disposable injector cartridge system.
Finally, the anterior chamber will be irrigated, the ocular
viscoelastic device will be removed, the wounds will be
secured by stromal hydration and the eye will be patched.
Phaco parameters
All the operations will be performed with Sovereign
compact phacoemulsiﬁcation system with WhiteStar
technology and Ellips (Abbott Medical Optics, Abbott
Laboratories, Abbott Park, Illinois, USA). During direct
chop, the parameters will be kept as follows: maximum
aspiration ﬂow rate: 28 cc/min, maximum vacuum:
295 mm Hg and threshold vacuum: 125 mm Hg;
maximum power: 30 continuous 6/12 (33%) with
Whitestar on and occluded 40 linear long pulse 6/12
(33%) with Whitestar on. The parameters for higher
grades of cataract will be as follows: maximum aspiration
ﬂow rate: 28 cc/min, maximum vacuum: 400 mm Hg
and threshold vacuum 250 mm Hg; maximum power: 40
continuous 6/12 (33%) with Whitestar on and occluded
40 linear long pulse 6/12 (33%) with Whitestar on.
Intraoperative evaluation
The parameters to be evaluated intraoperatively include
mean phaco power (%), effective phaco time (EPT)
(seconds) and phaco time using Ellips FX technology
(EFX). The EFX is roughly the EPT with a speciﬁc coef-
ﬁcient for the transversal movement of the phaco tip
expressed in seconds. Amount of irrigating ﬂuid used
will also be noted.
Postoperative evaluation
All the patients will be put on topical ciproﬂoxacin and
dexamethasone eye drops combination, one drop six times
a day for 1 week for the ﬁrst week, after which it will be
gradually tapered over a period of 1 month. All the patients
will be examined postoperatively on day 1, day 7 and at the
end of 1 month. The examinations will include UDVA,
CDVA, slit lamp biomicroscopy, applanation tonometry,
funduscopy and CCT measurement. Telephonic reminders
will be made to encourage the complete follow-up.
Outcome measure: The CCT will be measured on days 1,
7 and 30. Deturgescence of the corneal stroma is con-
trolled by the pumping action of the endothelial layer
and can be monitored by the measurement of CCT. Loss
or damage of endothelial cells leads to an increase in
corneal thickness, which may ultimately induce corneal
decompensation and loss of vision.13 A signiﬁcant linear
correlation exists between increase in corneal thickness
in the immediate postoperative period and percentage
of endothelial cell loss.14 Hence, CCT measurement can
be used as a simple tool to assess the amount of corneal
endothelial damage postcataract surgery.
Figure 1 shows the proposed ﬂow of the participants
in this trial.
Sample size calculation: The sample size calculation is
based on the anticipated differences in the CCT (mean
±SD) between the two groups. A sample of 50 in each
group is needed to detect a mean CCT difference of
20 µm with an SD of 35.3,15 1:1 allocation ratio, α error
of 0.05 and a power of 80%.16 The ﬁnal sample is
inﬂated to 55 with due consideration of 10% attrition.
Sensitivity analysis of sample size calculation for CCT: The
power of the study will be estimated based on the actual
number of the study participants who complete the
study and the observed differences in CCT across the
two study groups.
Randomisation and blinding
SS will generate the random sequence by computer-
generated random numbers and it will be secured in
sealed envelopes. SK will perform the surgeries and
RCV will assess the outcome. The trial participants,
outcome assessor and data analyst will be blinded.
DATA COLLECTION AND STATISTICAL ANALYSIS
A detailed statistical analysis plan will be prepared. A
blind review of the data will be performed after the end
of the planned follow-up period without looking at the
randomised treatment for each trial participant.
Attritions will be excluded from the analysis.
Intention-to-treat principle will be used for the analysis.
Results will be expressed in proportion and means
(±SD) for categorical and continuous variables, respect-
ively. Student’s t-test will be used to compare CCTs
between the study groups. A repeated measures analysis
of variance will be conducted to assess for any difference
in CCT between bevel-up and bevel-down groups over
time. All the data will be analysed using SPSS V.16.
Data monitoring committee
An independent data monitoring committee (DMC) will
be established. The DMC will monitor the course of the
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trial and if necessary will give a recommendation to the
main investigator of the trial for discontinuation, modiﬁ-
cation or continuation of the study and the same shall
be communicated to the University’s Ethics Committee
and Clinical Trial Registry of India.
Safety parameters
All the adverse events will be listed and displayed in
summary tables. The total number of adverse events, the
minimum, maximum and mean number of adverse
events per patient will be reported.
Study progress
The study began in January 2016, ethical approval and
trial registration number were obtained in February
2016. The recruitment will begin in April 2016.
DISCUSSION
The importance of preserving the corneal endothelium
during intraocular surgeries has been well established.
Postoperative corneal decompensation is rare when,
modern phaco technology is used in combination with
proper surgical techniques. However, there are several
patient-based factors that increase the likelihood of
corneal decompensation. With patients electing to have
cataract surgery and refractive lens exchange at increas-
ingly younger ages, protecting the endothelial cell layer at
all times is essential to avoid the potential for an epidemic
of pseudophakic bullous keratopathy in the future.17
Patient expectations after cataract surgery continue to
increase, and the patients anticipate perfect vision from as
early as the ﬁrst postoperative day.17 The main determin-
ant of a patient’s visual acuity on postoperative day 1 is the
Figure 1 Flow diagram of the trial participants. ACD, anterior chamber depth.
4 Kaup S, et al. BMJ Open 2016;6:e012024. doi:10.1136/bmjopen-2016-012024
Open Access
extent to which the endothelium has been protected.18
Hence, one must strive to achieve a surgical technique
which causes the least damage to the corneal endothe-
lium. This becomes even more imperative while operating
on patients who are prone to have a higher endothelial
cell loss during phacoemulsiﬁcation. These include
patients with shorter AL, small pupil, short ACD, high
nuclear grade, large nucleus, older age, etc.19–21 Hence, in
this study an attempt will be made to determine the effect
of altering the position of phaco tip (bevel-up vs bevel-
down) on CCT.
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